(Q48243272)

English

Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.

scientific article published on 15 January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

M. Angela Cenci Nilsson

6

object named as

M Angela Cenci

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

Wojciech Danysz

4

object named as

Wojciech Danysz

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

author name string

Flora Mela

1

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

Andrzej Dekundy

3

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

Michele Morari

5

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

language of work or name

0 references

publication date

15 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

101

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

2

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

483-497

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

The functional anatomy of basal ganglia disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Striatal fosB expression is causally linked with l-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Pathophysiology of levodopa-induced dyskinesia: potential for new therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Role of striatal L-DOPA in the production of dyskinesia in 6-hydroxydopamine lesioned rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Cellular and behavioural effects of the adenosine A2a receptor antagonist KW-6002 in a rat model of l-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Selective activation of group I metabotropic glutamate receptors upregulates preprodynorphin, substance P, and preproenkephalin mRNA expression in rat dorsal striatum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Glutamate cascade to cAMP response element-binding protein phosphorylation in cultured striatal neurons through calcium-coupled group I metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

The organization of the projection from the cerebral cortex to the striatum in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor f

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Levodopa motor complications in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

The metabotropic glutamate receptors: structure and functions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Alterations in striatal neuropeptide mRNA produced by repeated administration of L-DOPA, ropinirole or bromocriptine correlate with dyskinesia induction in MPTP-treated common marmosets.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

The effects of L-DOPA on regional cerebral glucose utilization in rats with unilateral lesions of the substantia nigra

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: implications for the therapy of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04456.X

21 January 2018

Identifiers

10.1111/J.1471-4159.2007.04456.X

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 February 2018

http://europepmc.org/abstract/MED/17359492

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48243272&oldid=2169348909"